The effects of body fluid biomarkers on neuropsychiatric disease
Not Applicable
Recruiting
- Conditions
- europsychiatric disease (mainly dementia)
- Registration Number
- JPRN-UMIN000017795
- Lead Sponsor
- ational Institute of Radiological Science, Molecular Neuroimaging Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Not provided
Exclusion Criteria
Only the subjects in the neuroimaging study of PET/MRI/CT are included.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The association of the biomarkers observed in cerebrospinal fluid/blood with their clinical data and imaging data.
- Secondary Outcome Measures
Name Time Method The clinical impact of the candidate biomarkers on the diagnosis of the neuropsychiatric disease.